Your browser doesn't support javascript.
loading
The severe COVID-19: A sepsis induced by viral infection? And its immunomodulatory therapy / 中华创伤杂志(英文版)
Chinese Journal of Traumatology ; (6): 190-195, 2020.
Article Dans Anglais | WPRIM | ID: wpr-827824
ABSTRACT
COVID-19 is known for its magical infectivity, fast transmission and high death toll based on the large number of infected people. From the perspective of the clinical manifestation, autopsy examination and pathophysiology, the essence of COVID-19 should be viewed as a sepsis induced by viral infection, and has the essential characteristics as sepsis induced by other pathogens. Therefore, in addition to etiological and supportive treatment, immunomodulatory therapy is also appropriate to severe COVID-19. Although there is still a lack of consensus on immunotherapy for sepsis so far, relatively rich experiences have been accumulated in the past decades, which will help us in the treatment of severe COVID-19. This article will elaborate immunotherapy of sepsis, though it may not be consistent.
Sujets)

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Pneumopathie virale / Glycoprotéines / Hormones corticosurrénaliennes / Infections à coronavirus / Sepsie / Utilisations thérapeutiques / Traitement médicamenteux / Pandémies / Betacoronavirus / Thymalfasine Limites du sujet: Humains langue: Anglais Texte intégral: Chinese Journal of Traumatology Année: 2020 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) Sujet Principal: Pneumopathie virale / Glycoprotéines / Hormones corticosurrénaliennes / Infections à coronavirus / Sepsie / Utilisations thérapeutiques / Traitement médicamenteux / Pandémies / Betacoronavirus / Thymalfasine Limites du sujet: Humains langue: Anglais Texte intégral: Chinese Journal of Traumatology Année: 2020 Type: Article